Carbetapentane tannate 6 mg/ML / phenylephrine tannate 1 mg/ML / pyrilamine tannate 6 mg/ML Oral Suspension [C-Tanna 12D]
RxNorm 603646

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 603646 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: carbetapentane tannate 6 mg/ML / phenylephrine tannate 1 mg/ML / pyrilamine tannate 6 mg/ML Oral Suspension [C-Tanna 12D].

The following semantic concepts and normalized strings are associated with this clinical entity:

SY
C-Tanna 12D (carbetapentane tannate 30 mg / phenylephrine tannate 5 mg / pyrilamine tannate 30 mg) per 5 mL Oral Suspension
AUI:11815509
View
SBD
Carbetapentane tannate 6 mg/ML / phenylephrine tannate 1 mg/ML / pyrilamine tannate 6 mg/ML Oral Suspension [C-Tanna 12D]
AUI:12362884
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SY

Synonym (SY):
C-Tanna 12D (carbetapentane tannate 30 mg / phenylephrine tannate 5 mg / pyrilamine tannate 30 mg) per 5 mL Oral Suspension
(Atom ID: 11815509)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
C-Tanna 12D (carbetapentane tannate 30 MG / phenylephrine tannate 5 MG / pyrilamine tannate 30 MG) per 5 ML Oral Suspension
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
603646
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
11815509
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
603646
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SBD

Semantic Branded Drug (SBD):
Carbetapentane tannate 6 mg/ML / phenylephrine tannate 1 mg/ML / pyrilamine tannate 6 mg/ML Oral Suspension [C-Tanna 12D]
(Atom ID: 12362884)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
carbetapentane tannate 6 MG/ML / phenylephrine tannate 1 MG/ML / pyrilamine tannate 6 MG/ML Oral Suspension [C-Tanna 12D]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
603646
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12362884
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBD
Semantic Branded Drug (Ingredient + Strength + Dose Form + Brand Name)
Source Code
603646
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{1037363} 221139
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1116161} 221070
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1293498} 221152
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{1037363} 8163
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1116161} 20217
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1293498} 9009
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1037363} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1116161} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1293498} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN OBSOLETED
04/30/2020
Date the RxNorm atom became obsolete
RXTERM FORM
Susp
The RxTerm dose form name for this drug